Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells (Q39423639)

11 September 2017

Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells (English)

1 reference

11 September 2017

Y Deng

1

1 reference

11 September 2017

J Cheng

2

1 reference

11 September 2017

B Fu

3

1 reference

11 September 2017

W Liu

4

1 reference

11 September 2017

G Chen

5

1 reference

11 September 2017

Q Zhang

6

1 reference

11 September 2017

Y Yang

7

1 reference

11 September 2017

language of work or name

English

0 references

publication date

5 September 2016

1 reference

11 September 2017

1 reference

11 September 2017

36

1 reference

11 September 2017

8

1 reference

11 September 2017

1090-1101

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2016.273

11 September 2017

0 references

cites work

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Myeloid derived suppressor cells in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Cancer associated fibroblasts (CAFs) in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Reconstruction of functionally normal and malignant human breast tissues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Molecular and cellular regulators of cancer angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Stem cells and niches: mechanisms that promote stem cell maintenance throughout life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

The role of IL-6 and STAT3 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

GM-CSF activates the Jak/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Tumor induction of VEGF promoter activity in stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.273

Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27593937

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A mechanism for modulation of cellular responses to VEGF: activation of the integrins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27593937

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2016.273

1 reference

11 September 2017

1 reference